Epistaxis; treatment with a new citrus flavinoid compound combined with vitamin K.
D000933:Antifibrinolytic Agents; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002957:Citrus; D004844:Epistaxis / Q000628:therapy*; D005419:Flavonoids / Q000627:therapeutic use*; D006490:Hemostatics; D006801:Humans; D012176:Retinoids; D014812:Vitamin K / Q000627:therapeutic use*; D014815:Vitamins
D000933:Antifibrinolytic Agents; D005419:Flavonoids; D006490:Hemostatics; D012176:Retinoids; D014815:Vitamins; D014812:Vitamin K; D001205:Ascorbic Acid
EPISTAXIS/therapy; VITAMIN C/therapeutic use; VITAMIN K/therapeutic use; VITAMIN P/therapeutic use